Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3896.47 | 578 / 578 | 97% | 26.43 | 1122 / 1155 |
intestine | 99% | 2338.08 | 958 / 966 | 95% | 37.48 | 501 / 527 |
breast | 100% | 1265.86 | 458 / 459 | 91% | 18.07 | 1018 / 1118 |
esophagus | 92% | 1006.90 | 1328 / 1445 | 95% | 28.73 | 173 / 183 |
skin | 100% | 1381.15 | 1801 / 1809 | 87% | 39.27 | 410 / 472 |
stomach | 89% | 662.47 | 318 / 359 | 96% | 36.48 | 274 / 286 |
kidney | 96% | 885.48 | 85 / 89 | 88% | 21.16 | 791 / 901 |
uterus | 95% | 689.05 | 161 / 170 | 85% | 25.78 | 392 / 459 |
ovary | 96% | 656.64 | 173 / 180 | 80% | 11.60 | 342 / 430 |
bladder | 86% | 1158.10 | 18 / 21 | 83% | 27.16 | 419 / 504 |
thymus | 90% | 651.48 | 586 / 653 | 68% | 9.77 | 412 / 605 |
prostate | 99% | 1103.19 | 242 / 245 | 56% | 5.28 | 280 / 502 |
liver | 80% | 444.48 | 181 / 226 | 58% | 6.85 | 237 / 406 |
adrenal gland | 94% | 586.14 | 242 / 258 | 30% | 3.53 | 69 / 230 |
pancreas | 34% | 173.73 | 112 / 328 | 89% | 20.59 | 158 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 38.49 | 29 / 29 |
spleen | 100% | 6856.26 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6798.37 | 924 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 1260.34 | 1196 / 1204 | 0% | 0 | 0 / 0 |
brain | 28% | 170.01 | 740 / 2642 | 68% | 12.48 | 478 / 705 |
tonsil | 0% | 0 | 0 / 0 | 96% | 24.35 | 43 / 45 |
heart | 79% | 471.55 | 676 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 66% | 481.91 | 886 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 4.10 | 24 / 80 |
muscle | 7% | 30.36 | 59 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1903265 | Biological process | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0046456 | Biological process | icosanoid biosynthetic process |
GO_0007165 | Biological process | signal transduction |
GO_0140448 | Biological process | signaling receptor ligand precursor processing |
GO_0051607 | Biological process | defense response to virus |
GO_0016540 | Biological process | protein autoprocessing |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0140970 | Biological process | AIM2 inflammasome complex assembly |
GO_0032741 | Biological process | positive regulation of interleukin-18 production |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0006508 | Biological process | proteolysis |
GO_0042742 | Biological process | defense response to bacterium |
GO_0007231 | Biological process | osmosensory signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006915 | Biological process | apoptotic process |
GO_0140447 | Biological process | cytokine precursor processing |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0051604 | Biological process | protein maturation |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0072558 | Cellular component | NLRP1 inflammasome complex |
GO_0005730 | Cellular component | nucleolus |
GO_0072559 | Cellular component | NLRP3 inflammasome complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005874 | Cellular component | microtubule |
GO_0072557 | Cellular component | IPAF inflammasome complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0097169 | Cellular component | AIM2 inflammasome complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061702 | Cellular component | canonical inflammasome complex |
GO_0097179 | Cellular component | protease inhibitor complex |
GO_0050700 | Molecular function | CARD domain binding |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0019900 | Molecular function | kinase binding |
GO_0019955 | Molecular function | cytokine binding |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0042802 | Molecular function | identical protein binding |
GO_0089720 | Molecular function | caspase binding |
GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CASP1 |
Protein name | CASP1 nirs variant 1 (Caspase 1) Caspase 1 (cDNA FLJ59442, highly similar to Caspase-1) Caspase 1 Caspase 1 (cDNA FLJ58540, highly similar to Caspase-1) Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] |
Synonyms | IL1BCE hCG_39362 IL1BC |
Description | FUNCTION: Thiol protease involved in a variety of inflammatory processes by proteolytically cleaving other proteins, such as the precursors of the inflammatory cytokines interleukin-1 beta (IL1B) and interleukin 18 (IL18) as well as the pyroptosis inducer Gasdermin-D (GSDMD), into active mature peptides . Plays a key role in cell immunity as an inflammatory response initiator: once activated through formation of an inflammasome complex, it initiates a pro-inflammatory response through the cleavage of the two inflammatory cytokines IL1B and IL18, releasing the mature cytokines which are involved in a variety of inflammatory processes . Cleaves a tetrapeptide after an Asp residue at position P1 . Also initiates pyroptosis, a programmed lytic cell death pathway, through cleavage of GSDMD . In contrast to cleavage of interleukin IL1B, recognition and cleavage of GSDMD is not strictly dependent on the consensus cleavage site but depends on an exosite interface on CASP1 that recognizes and binds the Gasdermin-D, C-terminal (GSDMD-CT) part . Cleaves and activates CASP7 in response to bacterial infection, promoting plasma membrane repair . Upon inflammasome activation, during DNA virus infection but not RNA virus challenge, controls antiviral immunity through the cleavage of CGAS, rendering it inactive . In apoptotic cells, cleaves SPHK2 which is released from cells and remains enzymatically active extracellularly . .; FUNCTION: [Isoform Delta]: Apoptosis inactive. .; FUNCTION: [Isoform Epsilon]: Apoptosis inactive. . |
Accessions | H0YEC7 ENST00000525825.6 [P29466-2] ENST00000695721.1 ENST00000533400.6 [P29466-1] ENST00000695716.1 ENST00000526568.5 [P29466-3] ENST00000532439.6 ENST00000695715.1 ENST00000695718.1 ENST00000695717.1 P29466 B4DVD8 ENST00000534497.5 [P29466-4] ENST00000695722.1 ENST00000528974.1 A0A8Q3SI00 ENST00000527979.5 ENST00000695720.1 ENST00000436863.7 [P29466-1] A0A8Q3SIY2 ENST00000529871.1 ENST00000531166.5 [P29466-5] A0A8Q3SI67 Q5FBZ0 ENST00000695714.1 G3V169 ENST00000695719.1 [P29466-2] B4DKN4 |